April  2017
CTSA Program Paves the Way for Nationwide Single IRB Model
Read the National Institutes of Health (NIH)  press release which highlights the success of the  Clinical and Translational Science Awards (CTSA) Program and the  NCATS Streamlined, Multisite, Accelerated Resources for Trials (SMART) IRB authorization agreement.

The CTSC is a SMART IRB participating institution. Learn about our local IRB resources here.
A New LinkedIn Page for CTSA Program KL2 Scholars
A component of the CTSA Program is the education and training of translational researchers. Most CTSA Program hubs, including our CTSC, have a KL2 program, which offers formal research training experience to scholars who already have an M.D., Ph.D., or equivalent doctoral degree.  

NCATS is pleased with the success of this program, and wishes to make the larger community aware of outstanding KL2 Scholars and their recent achievements. Hence, they have started a new LinkedIn page to feature scholars who have led innovative projects in the areas of workforce development, lifespan, methods and processes, collaboration and engagement, and informatics.

Research by former CTSC scholar, Jayme Knutson, PhD, is one of the first success stories to be featured on this new platform! 

Congratulations to the February Core Utilization Pilot Awardees!
Scott Welford, PhD
Case Western Reserve University School of Medicine
“Optimization of CPT1A Activity Measured by HPLC/Mass Spectrometry for Clinical Evaluation of Clear Cell Renal Cell Carcinoma”
Xin Yu, PhD
Case Western Reserve University Biomedical Engineering
“Delineation of Ischemic Penumbra in Post-Stroke Brain by MRI”
Collaboration/Engagement Domain Task Force
In last month's newsletter, we introduced Domain Task Forces (DTFs). This month, we highlight the Collaboration/Engagement DTF. The purpose of this DTF is to engage stakeholders to produce meaningful contributions, make team science a major academic model, and to promote shared leadership roles within the collaborative teams in translational science. Click here (PDF) to read the latest Collaboration/Engagement DTF news.
Researchers: Pure Experts can connect you with other researchers!
In an effort to promote multi-disciplinary clinical and translational research, the Clinical and  Translational Science Collaborative of Cleveland (CTSC) is pleased to introduce Pure Experts, a directory of researcher expertise that enables collaboration among researchers.

This expertise portal is a key component of the CTSC's mission to catalyze new knowledge 
and discovery to enhance and improve patient care and promote better health in the community.

Pure allows you to:
  • Capture and structure your research data centrally
  • Identify funding, expertise and collaborative partners
  • Report on the reliable, validated data
  • Analyze the progress of your teams and departments
  • Showcase your accomplishments
For more information about Pure, please see the Pure Brochure.
Do you know the difference between a PMID and a PMCID?
A PMID, also known as the PubMed reference number, is a number assigned by the NIH National Library of Medicine to papers indexed in PubMed.

The PMC reference number (PMCID) is assigned when the article is posted on PubMed Central. It is the proof of compliance that you must include when submitting applications, proposals, and reports to the NIH.

Have questions? Need help? Contact the CTSC at ctsc-administrator@case.edu.

View the full compliance checklist for submitting a manuscript.

News from the PRCHN
PRCHN Seminars
Healthy Neighborhoods
4/12/17 - 
Tobacco Retailer Density and Proximity to Schools: Associations with Lower Product Pricing and Increased Marketing 

The Future of Food in Your Neighborhood: the foodNEST Study

You can find more information on these seminars and other PRCHN programs   here.
For more news from PRCHN check out their  e-newsletter!

Using Tech to Evaluate Health
The associate director of the PRCHN, Darcy Freedman, recently published an article evaluating healthy food incentives programs. The article was published in the American Journal of Preventative Medicine and is titled "Dissemination of Technology to Evaluate Healthy Food Incentive Programs". 

FreshLink Is Hiring Community Members
FreshLink is hiring community members as FreshLink Ambassadors in the Cudell, Glenville, and University Circle neighborhoods. The Ambassadors will spread information about farmer's markets and Produce Perks through the communities.

HIP-Cuyahoga Adds New Key Approach
HIP-Cuyahoga has traditionally functioned on three key approaches, Community Engagement, Collective Impact, and Health and Equity in All Policies. Perspective Transformation was recently added, and is designed to encourage all people to engage with the world in a new way and act differently when it comes to racial inclusion. 

Special AJPM Supplement and Other New Publications
The PRCHN is proud to be part of the national network of 26 Prevention Research Centers (PRC) which celebrated its 30th anniversary during 2016. The American Journal of Preventative Medicine has released a special edition which covers accomplishments by PRC groups. Many PRCHN researchers are highlighted, and many more have publications. 

News from the Urban Health Intiative
The focus of activity this past month was participating in the first annual  Data Days, a series of events March 2-4 intended to elevate the work of many individuals and organizations focused on using data to improve life in Northeast Ohio.  Organized by the Center on Urban Poverty and Community Development at the Mandel School, CTRL + ALT +CLE included hands on skill training sessions, presentations, and peer-led discussions organized in an "Un-Conference" format.  Dr. Scott Frank led a workshop on Data Visualization 101 featuring the Health Data Matters LiveStories platform. I (Urban Health Director Amy Sheon) moderated a panel discussion on the implications of the digital divide for engaging underserved populations in health and clinical research.  Becky Gawelek from the Cuyahoga County Board of Health and I led a workshop to help participants use novel data sets on the Health Data Matters platform.  The Urban Health Initiative is now part of the Cleveland Civic Tech and Open Data Collaborative that planned Data Days, and will work with other partners to encourage government agencies to make data available for use by innovators and entrepreneurs.  

Creative Scientists' Proposed Recruitment Innovations
MetroHealth CRU Administrator Noreen Roman and I braved the Cleveland blizzard and a Nor'Easter to attend the  Creative Scientist Workshop hosted by the University of Buffalo CTSC. Intrepid travelers were richly rewarded with greater awareness of and ability to use innovative strategies to improve recruitment for clinical trials.  Talk to one of us to learn, for example, about how clinical researchers are using a telemedicine platform developed by another CTSA hub to expedite clinical trial recruitment and enrollment.  

The first annual  Medical Capital Innovation Competition, scheduled for April 25-26th has drawn a brisk response from applicants across the U.S. and even the world.  Next month, we'll report on who captured over $100,000 in prize money for the best innovations in using data to improve health and health care.  If you are interested in serving as a mentor or a judge for the competition, please contact Amy.Sheon@case.edu.
News from our Colleagues
Request for Applications: 
Opportunities for Pilot Projects in Genomics
DEADLINE: Friday, April 21, 2017
The Case Comprehensive Cancer Center is providing seed funding for the initiation of novel projects that focus on genomic analyses of tissue/blood samples from patients seen at University Hospitals of Cleveland. Projects must be aligned with at least one of the seven Research Programs (GI Cancer Genetics, Molecular Oncology, GU Malignancies, Hematopoietic and Immune Cancer Biology, Developmental Therapeutics, Cancer Imaging, or Cancer Prevention, Control, & Population Research) or the Brain Tumor, Breast Cancer, or AYA research initiatives within the Center. Highly innovative and impactful proposals are sought that will generate key data for larger, nationally competitive grants that interface with the Strategic Plan of the aligned program(s). Collaborative, multi-investigator projects are particularly encouraged. Analysis of samples obtained from patients in clinical trials, high risk families, or underserved populations are particularly encouraged. Use of genomics tools is required with preference for sequencing and analytics studies preferred through the genomics shared resource or through UHTL. IRB review may be pending at the time of submission.

Award Description
  • Funding for research teams with projects that are aligned with one of the Cancer Center Research Programs or Initiatives.
  • Up to 5 research projects will be funded. Total funds committed to this RFA are $250,000.
  • Each research project can request a budget of up to $50,000 for one year.
  • Research projects should be completed within 1 year

Funding Criteria 

  • Strong collaborative investigative teams of Case Comprehensive Cancer Center members that clearly demonstrate programmatic alignment.
  • PI must be at the rank of Assistant Professor or higher at CWRU at the time of submission. * Highly innovative and impactful projects.
  • All materials to complete the project should be in-hand or readily available. At the time of award, an approved IRB protocol for patient cohort collection will be needed. Collection of new patient cohorts is responsive to this RFA with IRB approval.
  • Projects must have a high likelihood of subsequent national-level funding.
  • While investigators can be collaborators on multiple applications, only one application will be accepted per lead PI.
  • It is preferred that funds for core facilities use Case Comprehensive Cancer Center cores, when available.

Contact  casecccpilots@case.edu or Megan Kilbane at  216.286.4440 with any questions. 

NCATS Achieves Milestone to Speed Multisite Clinical Studies

All Clinical and Translational Science Awards Program sites have signed on to the NCATS Streamlined, Multisite, Accelerated Resources for Trials Institutional Review Board authorization agreement, making it possible to initiate multisite clinical studies within weeks instead of months. 

View CTSC Regulatory Knowledge Support for more information regarding practices at the Cleveland CTSA.

From our Colleagues at the NIH
From our Colleagues at Tufts University

Online Graduate Certificate in Fundamentals of Clinical Care Research

Beginning in July 2017, Tufts University Sackler School of Graduate Biomedical Sciences will offer an Online Graduate Certificate in Fundamentals of Clinical Care Research (CCR) that provides clinicians and scientists with graduate-level training in the methods and conduct of clinical research. 

The Fundamentals of CCR curriculum combines asynchronous lectures with participation in interactive webinars and active discussion boards, allowing for flexible yet dynamic interaction between faculty and students. The program is three courses (2.5 credits, one course per semester):

  • Elements of Epidemiology for Clinical Research
  • Principles of Biostatistics for Clinical Research
  • Survey of Clinical Care Research 

Eligible applicants for the Fundamentals of CCR Certificate should hold a professional degree (e.g., MD, DDS, DVM) or a master’s or doctoral degree in a health-related field. Exceptional candidates with a prior bachelor’s degree (or non-US equivalent) in the sciences and a demonstrated interest in clinical research will be considered. 

Applications are being accepted now through May 1, 2017 at: https://gradhlthsci.admissions.tufts.edu/apply/?sr=1749ce1a-0ca0-46a0-8055-7c7ecac3b956

For more information, please visit: http://www.tuftsctsi.org/education/clinical-and-translational-science-graduate-program/online-graduate-certificate-in-fundamentals-of-clinical-care-research/

Research Highlights
Mahmoud Ghannoum Identifies Effects of Investigational Drug
The deadly fungus, Candida auris, has been found in hospitals around the world, and is resistant to most known antimicrobial drugs. The fungus is often found in intensive care units on items such as catheters. By mimicking this environment, Mahmoud Ghannoum and team became the first to identify the effects of the investigational drug  (SCY-078), which severely distorts and impairs the growth of the fungus. Ghannoum’s research provides a foundation for future clinical trials investigating the use of antimicrobials. 

In 2009, Ghannoum received a CTSC core utilization pilot award. 

Read the daily article or the full paper for more information.
Researchers Receive DOD Funding for Spinal Cord Injury Research
Researchers from the Cleveland Clinic, University of British Colombia, and ProTransit Nanotherapy LLC have received a Department of Defense grant for their research on acute spinal cord injury therapy. They were awarded $1.7 million to improve an injectable treatment which reduces the size of the cavity formed in the spinal cord after the initial injury. The injection is being developed as a treatment meant to be used during transit to a medical site.
Vinod Labhasetwar, PhD, is the principal investigator on the project. He runs a lab with a focus on researching translational nanomedicine and is a leader for the Cancer NanoMedicine program. Additionally, Labhasetwar is a reviewer for the CTSC Pilot Grant Program.

The award was mentioned in Crain's Cleveland Business this past month.
Quadriplegic Uses Arm with Help From Injury Bridging Technology
Researchers from CWRU, Louis Stokes VA, and University Hospitals have made strides in paralysis research. Through the use of Functional Electrical Stimulation (FES) and an implanted Brain-Computer Interface (BCI), Bill Kochevar, a man with quadriplegia, was able to drink water and eat potatoes on his own. The combination of devices is an exciting find and the researchers hope to fit the devices for at home use.

Bob Kirsch is the Principal Investigator on the project and Chair of CWRU's Department of Biomedical Engineering. A. Bolu Ajiboye and KL2 Scholar, Jennifer Sweet, were notably involved in the research.

Read the full article in the daily.
Seminar in Multidisciplinary Clinical and Translational Research
WRB 6136 from 12-1 pm
April 10, 2017 - Jim Werner, PhD, Associate Professor, Dept. of Family Medicine & Community Health, CWRU, will discuss  "Practice-Based Research Networks: Essential Infrastructure for Translational Research"

For questions contact Angela Bowling (axb710@case.edu).

Medical Capital Innovation Competition
April 25-26, 2017
The inaugural  Medical Capital Innovation Competition  invites professional and collegiate teams to offer up their best big-data ideas for a chance at $100,000 in prizes along with critical feedback from Cleveland's world-renowned healthcare sector. The two-day event is hosted by The Global Center for Health Innovation  ( GCHI), Cuyahoga County,  BioEnterprise, and the Healthcare Information and Management Systems Society ( HIMSS) and will be held April 25-26 at GCHI's Innovation Center.

Annual Department of Medicine Research Day
May 12, 2017

The Department of Medicine Research Day will be held on Friday, May 12, 2017 at the Wolstein Research Building.  Information regarding registration and abstract submission can be found at http://www.cwrumedicine.org/research-day .

For more information please contact Martha Salata at 844-1988 or mks18@case.edu.

CRSP 401 "Introduction to Clinical Research"
Application Deadline: May 15, 2017
Seminars will be held from July 5 - 27, 2017 in the mornings in the Wolstein Research Building.

If you would like to apply please read fully this  informational flyer and the instructions for both  Non-CRF applications and  Non-Degree applications.

For questions contact Angela Bowling (axb710@case.edu).

Save the Date! OHRP Research Community Forum
September 6-7, 2017
Northern Kentucky Convention Center, Covington, KY
The Cincinnati CTSA will be hosting a two-day human subject protection forum consisting of an academic conference and an applied workshop relevant for institutional review board (IRB) members, IRB administrators, clinical investigators, research scientists and support staff, sponsors, contract research organizations, government regulators, and members of the research community.
Representatives from the Office of Human Research Protection (OHRP) and other federal agencies as well as research experts will provide perspectives and resources for interpreting and applying human subject protections in an evolving regulatory landscape.
Tracks include:
  •          Social/behavioral research
  •          Biomedical research
  •          Innovative research
  •          Regulatory landscape
  •          Community engagement
Registration information and full agenda coming soon!

Funding Opportunities
Special Funding Opportunity

The Case Western Center for Reducing Health Disparities will be leading CWRU's application for an NIH-funded Specialized Center for Research on Minority Health and Health Disparities.

If you are interested in participating to the application, please contact Dr. Ash Sehgal (216-778-7728 or sehgal@case.edu).

Research Initiative Details
This Notice encourages investigators with expertise and insights into the science of health disparities, particularly the complex interplay between risk and protective factors acting at multiple levels across the life course, to begin to consider applying for this new FOA.

The FOA will encourage collaborative activities combining expertise in biomedical and behavioral research, research education, clinical and health services research, social science, environmental health science, population science, translational science, implementation science, and the science of community engagement. Each COE is expected to have a thematic focus in a specific scientific area that may include, but are not limited, to social determinants of health, men's health, women's health, maternal and child health, chronic disease prevention, environmental health disparities, precision medicine, health services and policy research. The COEs will be expected to work closely with community partners to facilitate development of programs that can be implemented in real-world settings to improve minority health and reduce health disparities.

Projects must include a focus on one or more NIH-designated health disparity populations, which include Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Asian Americans, Native Hawaiians and Other Pacific Islanders, socioeconomically disadvantaged populations, underserved rural populations, and sexual and gender minorities.

NSF: Advanced Biomanufacturing of Therapeutic Cells
Application Deadline: April 17, 2017
In recent years, somatic cells as therapeutic agents have provided new treatment approaches for a number of pathological conditions that were deemed untreatable, or difficult to treat. Several successful cell therapies using T cells have been demonstrated for cancer and autoimmune diseases, while stem cell therapies have given relief for heart disease and stroke. Hundreds of clinical trials are ongoing to examine efficacy of cell therapies for a variety of other diseases including diabetes, Alzheimer's, Parkinson's, and Crohn's disease. Production of therapeutic cells is currently expensive and, therefore, cost prohibitive for the large number of people who might benefit from these treatments. The overarching goal of this Advanced Biomanufacturing of Therapeutic Cells (ABTC) solicitation is to catalyze well-integrated interdisciplinary research to understand, design, and control cell manufacturing systems and processes that will enable reproducible, cost-effective, and high-quality production of cells with predictable performance for the identified therapeutic function. 

Application Deadline: April 17, 2017

For more information visit the Grants.Gov website.

Sigma Theta Tau International
Application Deadline: May 1, 2017
Founded in 1922,  Sigma Theta Tau International supports the learning, knowledge, and professional development of nurses working to make a difference in global health.

To that end, the organization is inviting applications from registered nurses for its Global Nursing Research Grant program. Through the program, a single grant of up to $10,000 is awarded annually to encourage nurses to focus on responding to health disparities globally. 

To be eligible, the principal investigator(s) should be a registered nurse (or country equivalent) with a current license and have at least a master's in nursing (or country equivalent). Preference will be given to Sigma Theta Tau members. 

Application Deadline: May 1, 2017

For more information visit the  STTI website.
Bill & Melinda Gates Foundation
Application Deadline: May 3, 2017

The Bill & Melinda Gates Foundation is inviting proposals for the latest round of Grand Challenges Explorations. Grand Challenges Explorations fosters early-stage discovery research to expand the pipeline of ideas for solving our greatest global health and development challenges. Launched in 2008 with an initial $100 million commitment from the foundation, Grand Challenges Explorations grants have already been awarded to more than 1200 researchers in more than 65 countries.

Applicants can be at any experience level; in any discipline; and from any organization, including colleges and universities, government laboratories, research institutions, non-profit organizations, and for-profit companies. Initial grants will be US $100,000 each, and projects showing promise will have the opportunity to receive additional funding of up to US $1 million. 

Applications will be accepted on the following four topics:

  • Health Systems Strengthening: Ensuring Effective Health Supply Chains;
  • New Approaches for Improving Timeliness of Routine Immunizations in Low-Resource Settings;
  • Wearables and Technology for Maternal, Neonatal and Child Health Behavior Change;
  • Innovations for Integrated Diagnostics Systems;

Application Deadline: May 3, 2017

For more information visit the Grand Challenges website.

Taub Foundation
Application Deadline: May 19, 2017
The  Taub Foundation Grants Program for Myelodysplastic Syndromes (MDS) Research was created to support high-impact, innovative, translational research to understand the underlying causes of MDS and to advance its treatment and prevention.

Innovative studies with transformative potential to elucidate MDS etiology and to develop new treatments are particularly encouraged. Proposals focused on the progression of MDS to AML are not within the scope of this funding. 

The Taub Program supports independent investigators at all stages of their careers. To promote the expansion of the MDS research field collaborative efforts and proposals from young investigators and those from non-MDS fields are encourage to apply. 

Application Deadline: May 19, 2017

For more information visit the  Taub Foundation website.
Alex's Lemonade Stand Foundation
Application Deadline: May 22, 2017
Alex's Lemonade Stand Foundation evolved from the front yard lemonade stand of cancer patient Alexandra "Alex" Scott (1996-2004) into a national fundraising movement to raise awareness and find cures for all childhood cancers.

The purpose of the foundation's Reach Awards program is to advance its mission to find cures and better treatments for childhood cancers by providing support to move hypothesis-driven research into the clinic. To that end, the program supports late translational studies needed to ultimately initiate a clinical trial. Priority will be given to those research projects which, if funded, will result in the initiation of a clinical trial within two to three years. 

A successful application will identify an unmet clinical need relevant to the care of patients with pediatric cancer and describe how the work performed will allow for the translation of hypothesis-driven research to the clinic keeping broader clinical testing and implementation in view. 

Grants of up to $250,000 will be awarded over two years. 

Primary applicants may be an assistant-, associate-, or professor-level investigator with a track record of discovery, investigation, and external funding. Applicants may be an M.D., D.O., Ph.D, or M.D./Ph.D. In addition, applicants must have a demonstrated track record of pediatric cancer research and have experience in translational research. Multiple investigator applications that bring together pairs or teams of researchers with complementary expertise are encouraged.

Application Deadline: May 22, 2017

For more information visit the  Alex’s Lemonade website.
Centers for Disease Control - Racial and Ethnic Approaches to Community Health (REACH)
Application Deadline: May 23, 2017
Chronic diseases and their outcomes disproportionately impact racial and ethnic populations including African Americans/Blacks, Hispanic Americans, Asian Americans, Native Hawaiian/Other Pacific Islanders, American Indians and Alaska Natives. Attention to improving the access to high-quality nutrition, opportunities for physical activity and providing a smoke-free environment for young children are critical steps in reducing health disparities. The purpose of this FOA is to provide communities the opportunity to improve poor health, prevent chronic diseases and reduce health disparities among racial and ethnic populations with the highest risk, or burden, of chronic disease. Eligible applicants are unrestricted. Grant recipients will receive up to $1 million. 

Application Deadline: May 23, 2017

For more information visit the  Grants.Gov website.

Howard Hughes Medical Institute (HHMI) - 2018 HHMI Investigator Competition
Application Deadline: June 27, 2017

The Howard Hughes Medical Institute (HHMI) has announced that it seeks to appoint up to 20 new biomedical researchers through a national open competition. HHMI recently increased the standard term for HHMI investigators from five to seven years, providing longer term, flexible support as these scientists explore new research territory. The initiative represents an investment of approximately $168 million in basic biomedical research over the next seven years.

The HHMI investigator competition is open to basic researchers and physician scientists at more than 200 eligible institutions who bring innovative approaches to the study of biological problems in biomedical disciplines, plant biology, evolutionary biology, biophysics, chemical biology, biomedical engineering, and computational biology. Those selected in this competition will receive a seven-year appointment to HHMI, which is renewable pending favorable scientific review.

HHMI encourages its investigators to push their research fields into new areas of inquiry. By employing scientists as HHMI investigators—rather than awarding them research grants—the Institute is guided by the principle of “people, not projects.” HHMI investigators have the freedom to explore and, if necessary, to change direction in their research. Moreover, they have support to follow their ideas through to fruition—even if that process takes many years.

Application Deadline: June 27, 2017

For more information visit the HHMI website.

Little Giraffe Foundation
Application Deadline: July 14, 2017
The  Little Giraffe Foundation  is dedicated to funding neonatal research and supporting patients and parents of the NICU. The foundation is accepting Letters of Intent for 2017.

Grants of up to $10,000 will be awarded to qualified scientists, doctors, and nurses at universities, hospitals, and research institutions in support of research that addresses both the long-term and immediate health needs caused by premature birth as well as the causes of premature birth and ways to prevent it. Research subjects appropriate for support include basic biological processes governing development, genetics, clinical studies, studies of reproductive health, environmental toxicology, and social and behavioral studies. 

Letter of Intent Deadline: July 14, 2017

For more information visit the Little Giraffe website.

NIH: Neoantigen-Based Therapeutic Targeting of Head and Neck Cancers (R01)
Application Deadline: July 19, 2017
The purpose of this Funding Opportunity Announcement (FOA) is to support basic and preclinical research aimed at developing novel immunotherapeutic targets for head and neck cancers (HNC), including salivary gland cancers. Research supported by this FOA will identify human HNC-specific neoantigens, and will test the utility of these neoantigens as targets for eliciting anti-tumor immune responses in affected patient populations. 

Application deadline is July 19, 2017. 

For more information visit the  NIH website.
Special Funding Opportunities
Multiple Deadlines
NIDCR Prospective Observational or Biomarker Clinical Validation Study Cooperative Agreement (U01)

Notice of Intent to Publish a Funding Opportunity Announcement for the National Centers for Translational Research in Reproduction and Infertility (P50) 

NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3)

Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories (U01)

NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01)

National Cooperative Drug/Device Discovery/Development Groups (U01) 

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Addiction (U19) 

Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21)

Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03)

Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01)

Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R18)

Evaluating Natural Experiments in Healthcare to Improve Diabetes Prevention and Treatment (R18)

Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R34)

Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R21)

Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R01)

Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R01) 

Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R21) 

From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (Collaborative U01)

Advancing the Science of Geriatric Palliative Care (R01)

Advancing the Science of Geriatric Palliative Care (R21)

Resource-Related Research Projects in the Epidemiology and Prevention of Pediatric Injury (R24)
NIH-Industry Program Opportunities
Multiple Deadlines
Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02)
  • National Center for Advancing Translational Sciences
  • Application Receipt Date(s): April 17, 2017, by 5:00 pm local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (UG3/UH3) 


  • National Center for Advancing Translational Sciences
  • National Institute of Dental and Craniofacial Research
  • Application Receipt Date(s): September 15, 2017, by 5:00 pm local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 
Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses for Existing Molecules (UG3/UH3) 


  • National Center for Advancing Translational Sciences
  • National Institute of Dental and Craniofacial Research
  • Application Receipt Date(s): September 15, 2017, by 5:00 pm local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No Late applications will be accepted for this FOA. 
NCATS Pilot Program for Collaborative Drug Discovery Research using Bioprinted Skin Tissue (U18)


  • National Center for Advancing Translational Sciences
  • Application Receipt Date(s): April 14, 2017

Department of Defense